https://www.has-sante.fr/jcms/p_3305389/fr/leukotac-inolimomab https://www.has-sante.fr/jcms/p_3305404/fr/decision-n-2021-0341/dc/sem-du-16-decembre-2021-du-college-de-la-haute-autorite-de-sante-portant-refus-de-la-demande-d-acces-precoce-de-la-specialite-leukotac-inolimomab 2021 false false false France adult adolescent child infant graft vs host disease acute disease hematopoietic stem cell transplantation transplantation, homologous immunosuppressive agents infusions, intravenous evaluation of the transparency committee inolimomab
--- https://ansm.sante.fr/tableau-atu-rtu/leukotac-1-mg-ml-solution-a-diluer-pour-perfusion 2021 false false false France French summary of product characteristics package leaflet guidelines for drug use inolimomab